6th EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry
Rehovot, Israel November 15-18, 2015
Technion-Israel Institute of Technology, Haifa, Israel
Novo Nordisk, Cambridge, United States
University of Antwerp, Antwerp, Belgium
Chembridge Corporation, San Diego, United States
Chembridge Corporation, San Diego, United States
Bar Ilan University, Ramat Gan, Israel
Technion-Israel Institute of Technology, Haifa, Israel
Teva Pharmaceutical Industries, Petah Tikva, Israel
Novo Nordisk, Cambridge, United States
The Hebrew University of Jerusalem, Jerusalem, Israel
Temple University, Philadelphia, United States
Novartis Institutes for Biomedical Research, Basel, Switzerland
Pfizer Neusentis, Deal, United Kingdom
ETH Zürich, Zürich, Switzerland
MERCK KGaA, Darmstadt, Germany
UCB Biopharma, Brussels, Belgium
SCT & Institut de Recherches Servier, Paris, France
Janssen R&D, Belgium
RICE University, Houston, United States
Bayer HealthCare, Berlin, Germany
University of Perugia, Corciano, Italy
Max Planck Institute of Colloids and Interfaces, Berlin, Germany
F. Hoffmann-La Roche Ltd, Basel, Switzerland
Pfizer, Stevenage, Herts, SG1 2NY, United Kingdom